Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Nishimura

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2004
[Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer]Wasaburo Koizumi, Satoshi Tanabe, Katsuhiko Higuchi, et al.
Anticancer Research|November 11, 2006
Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancerWasaburo Koizumi, Satoshi Tanabe, Katsuhiko Higuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 17, 2006
[A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor]Norisuke Nakayama, Satoshi Tanabe, Wasaburo Koizumi, et al.
Stem Cell Research|July 1, 2017
Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302Ken Nishimura, Manami Ohtaka, Hitomi Takada, et al.
Development (Cambridge, England)|May 30, 2015
Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cellsHideki Masaki, Megumi Kato-Itoh, Ayumi Umino, et al.
Regenerative Therapy|December 8, 2018
Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectorsKoichiro Nishino, Yoshikazu Arai, Ken Takasawa, et al.
Case Reports in Gastroenterology|March 9, 2018
A Bile Duct Stone Formation around a Fish Bone as a Nidus after PancreatoduodenectomyTomoki Sakakida, Hideki Sato, Toshifumi Doi, et al.
International Journal of Clinical Oncology|November 25, 2024
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomyKazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, et al.
Annals of Gastroenterological Surgery|May 19, 2025
Impact of gastrectomy on efficacy and safety of second-line chemotherapy patients with advanced gastric cancer: Exploratory analysis of two randomized phase III trialsKazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2011
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)Wasaburo Koizumi, Norisuke Nakayama, Satoshi Tanabe, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2004
[Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer]Wasaburo Koizumi, Satoshi Tanabe, Katsuhiko Higuchi, et al.
Anticancer Research|November 11, 2006
Optimal dose-finding study of bi-weekly paclitaxel in unresectable advanced or recurrent gastric cancerWasaburo Koizumi, Satoshi Tanabe, Katsuhiko Higuchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 17, 2006
[A case of long-term survival of 3-years 4 months after combination chemotherapy of MTX, 5-FU and low-dose CDDP (MFP) for type 4 gastric cancer with pleuritis, peritoneal dissemination and Krukenberg tumor]Norisuke Nakayama, Satoshi Tanabe, Wasaburo Koizumi, et al.
Stem Cell Research|July 1, 2017
Simple and effective generation of transgene-free induced pluripotent stem cells using an auto-erasable Sendai virus vector responding to microRNA-302Ken Nishimura, Manami Ohtaka, Hitomi Takada, et al.
Development (Cambridge, England)|May 30, 2015
Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cellsHideki Masaki, Megumi Kato-Itoh, Ayumi Umino, et al.
Regenerative Therapy|December 8, 2018
Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectorsKoichiro Nishino, Yoshikazu Arai, Ken Takasawa, et al.
Case Reports in Gastroenterology|March 9, 2018
A Bile Duct Stone Formation around a Fish Bone as a Nidus after PancreatoduodenectomyTomoki Sakakida, Hideki Sato, Toshifumi Doi, et al.
International Journal of Clinical Oncology|November 25, 2024
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomyKazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, et al.
Annals of Gastroenterological Surgery|May 19, 2025
Impact of gastrectomy on efficacy and safety of second-line chemotherapy patients with advanced gastric cancer: Exploratory analysis of two randomized phase III trialsKazuhiro Nishikawa, Wasaburo Koizumi, Akira Tsuburaya, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2011
A multicenter phase II study of combined chemotherapy with docetaxel, cisplatin, and S-1 in patients with unresectable or recurrent gastric cancer (KDOG 0601)Wasaburo Koizumi, Norisuke Nakayama, Satoshi Tanabe, et al.
Pageof 10